Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Snap-on Inc Director's Dealing 2023

Feb 14, 2023

30335_dirs_2023-02-13_c61689d6-5264-45e9-8763-9b1c81adc2f7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Snap-on Inc (SNA)
CIK: 0000091440
Period of Report: 2023-02-09

Reporting Person: Pagliari Aldo John (Sr VP - Finance & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-09 Common Stock M 10000 $109.43 Acquired 87541.2909 Direct
2023-02-09 Common Stock S 2190 $250.23 Disposed 85351.2909 Direct
2023-02-09 Common Stock S 1700 $251.7063 Disposed 83651.2909 Direct
2023-02-09 Common Stock S 1934 $252.8475 Disposed 81717.2909 Direct
2023-02-09 Common Stock S 1206 $253.704 Disposed 80511.2909 Direct
2023-02-09 Common Stock M 4300 Acquired 84811.2909 Direct
2023-02-09 Common Stock F 2021 $249.26 Disposed 82790.2909 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-09 Stock Option (Right to Buy) $109.43 M 10000 Disposed 2024-02-13 Common Stock (10000) Direct
2023-02-09 Performance Units $ A 1460 Acquired Common Stock (1460) Direct
2023-02-09 Performance Units $ M 4300 Disposed Common Stock (4300) Direct
2023-02-09 Stock Option (Right to Buy) $249.26 A 7850 Acquired 2033-02-09 Common Stock (7850) Direct
2023-02-09 Restricted Stock Units $ A 1793 Acquired 2026-02-09 Common Stock (1793) Direct
2023-02-09 Performance Units $ A 3586 Acquired Common Stock (3586) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $144.69 2025-02-12 Common Stock (34000) 34000 Direct
Stock Option (Right to Buy) $138.03 2026-02-11 Common Stock (35000) 35000 Direct
Stock Option (Right to Buy) $168.70 2027-02-09 Common Stock (36000) 36000 Direct
Stock Option (Right to Buy) $161.18 2028-02-15 Common Stock (26052) 26052 Direct
Stock Option (Right to Buy) $155.92 2029-02-14 Common Stock (23500) 23500 Direct
Stock Option (Right to Buy) $155.34 2030-02-13 Common Stock (23500) 23500 Direct
Stock Option (Right to Buy) $189.89 2031-02-11 Common Stock (14986) 14986 Direct
Stock Option (Right to Buy) $211.67 2032-02-10 Common Stock (11252) 11252 Direct
Restricted Stock Units $ 2024-02-11 Common Stock (2337) 2337 Direct
Restricted Stock Units $ 2025-02-10 Common Stock (1924) 1924 Direct
Performance Units $ Common Stock (4673) 4673 Direct
Performance Units $ Common Stock (3847) 3847 Direct

Footnotes

F1: The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan.

F2: This transaction was executed in multiple trades at prices ranging from $249.95 to $250.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

F3: This transaction was executed in multiple trades at prices ranging from $251.32 to $252.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

F4: This transaction was executed in multiple trades at prices ranging from $252.35 to $253.335. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

F5: This transaction was executed in multiple trades at prices ranging from $253.40 to $254.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

F6: Based on Company performance during the 2020-2022 period, approximately 151.4% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits).

F7: Shares were withheld to cover tax withholding upon the vesting of performance units.

F8: Option fully vested.

F9: Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan.

F10: 1 for 1.

F11: Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.

F12: The transaction was an option grant. Accordingly, the reporting person did not pay a price to obtain the option.

F13: The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.

F14: If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.

F15: If the Company achieves certain goals over the 2021-2023 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.

F16: If the Company achieves certain goals over the 2022-2024 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.